Sera prognostics, inc.SERA.US Overview

US StockHealthcare

(No presentation for SERA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

SERA Overall Performance

SERA AI Analysis & Strategy

SERA Recent Performance

-0.28%

Sera prognostics, inc.

0.81%

Avg of Sector

-1.14%

S&P500

SERA PowerScanner

SERA Key Information

SERA Valuation Metrics

SERA Earnings Table

SERA Profile

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.